Development of Nanobody-Displayed Whole-Cell Biosensors for the Colorimetric Detection of SARS-CoV‑2

The accurate and effective detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is essential to preventing the spread of infectious diseases and ensuring human health. Herein, a nanobody-displayed whole-cell biosensor was developed for colorimetric detection of SARS-CoV-2 spike...

Full description

Saved in:
Bibliographic Details
Published inACS applied materials & interfaces Vol. 15; no. 31; pp. 37184 - 37192
Main Authors He, Yawen, Xu, Zhiyuan, Kasputis, Tom, Zhao, Xue, Ibañez, Itati, Pavan, Florencia, Bok, Marina, Malito, Juan Pablo, Parreno, Viviana, Yuan, Lijuan, Wright, R. Clay, Chen, Juhong
Format Journal Article
LanguageEnglish
Published United States American Chemical Society 09.08.2023
Subjects
Online AccessGet full text
ISSN1944-8244
1944-8252
1944-8252
DOI10.1021/acsami.3c05900

Cover

More Information
Summary:The accurate and effective detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is essential to preventing the spread of infectious diseases and ensuring human health. Herein, a nanobody-displayed whole-cell biosensor was developed for colorimetric detection of SARS-CoV-2 spike proteins. Serving as bioreceptors, yeast surfaces were genetically engineered to display SARS-CoV-2 binding of llama-derived single-domain antibodies (nanobodies) with high capture efficiency, facilitating the concentration and purification of SARS-CoV-2. Gold nanoparticles (AuNPs) employed as signal transductions were functionalized with horseradish peroxidase (HRP) and anti-SARS monoclonal antibodies to enhance the detection sensitivity. In the presence of SARS-CoV-2 spike proteins, the sandwiched binding will be formed by linking engineered yeast, SARS-CoV-2 spike proteins, and reporter AuNPs. The colorimetric signal was generated by the enzymatic reaction of HRP and its corresponding colorimetric substrate/chromogen system. At the optimal conditions, the developed whole-cell biosensor enables the sensitive detection of SARS-CoV-2 spike proteins in a linear range from 0.01 to 1 μg/mL with a limit of detection (LOD) of 0.037 μg/mL (about 4 × 108 virion particles/mL). Furthermore, the whole-cell biosensor was demonstrated to detect the spike protein of different SARS-CoV-2 variants in human serum, providing new possibilities for the detection of future SARS-CoV-2 variants.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:1944-8244
1944-8252
1944-8252
DOI:10.1021/acsami.3c05900